New Study Links Gabapentin Use in Adults 35-64 to Increased Risk of Dementia and Cognitive Decline
Emerging research has raised significant concerns about the long-term cognitive effects of gabapentin, a common medication prescribed for chronic pain. According to a recent study published in 2024, adults aged 35 to 64 who use gabapentin are twice as likely to develop dementia and three times more likely to experience mild cognitive impairment compared to those who do not take the drug. Gabapentin, frequently marketed under brand names such as Neurontin, has become a widely used treatment for neuropathic pain, fibromyalgia, and certain seizures. Its perceived safety profile has led to exponential growth in prescriptions, especially for chronic pain management.












